Ming c liau (4 resultados)

Taschenbuch. Condición: Neu. Destabilization of Abnormal Methylation Enzymes to Combat Cancer | The Nature's Choice to Win the War on Cancer | Ming C. Liau (u. a.) | Taschenbuch | 60 S. | Englisch | 2020 | LAP LAMBERT Academic Publishing | EAN 9786202668897 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. …

Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The therapeutic end point of destabilization of abnormal methylation enzymes is terminally differentiated cells. This end point is compatible with the end point on the therapy of hematological cancers. It can fit in on the therapy of hematological cancers, but it will not be easy for the acceptance on the therapy of solid cancers. In combination with surgery, or cytotoxic chemotherapy to pursue the end point of tumor disappearance is perhaps an easy way out. Different end points, however, have to be sought to legitimate differentiation therapy. End point of the disappearance of circulating cancer stem cells, or restoration of plasma/urine peptide ratios to those of healthy people are valid, but need careful studies before being accepted as valid end points. 60 pp. Englisch. …

Kartoniert / Broschiert. Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: C. Liau MingDr. Ming C. Liau received Ph. D. in Biochemistry in 1966 from Baylor College of Medicine. He dedicated his entire life on cancer research. Dr. Kim is a cancer biologist with background in Angiogenesis and has been work.…

Taschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The therapeutic end point of destabilization of abnormal methylation enzymes is terminally differentiated cells. This end point is compatible with the end point on the therapy of hematological cancers. It can fit in on the therapy of hematological cancers, but it will not be easy for the acceptance on the therapy of solid cancers. In combination with surgery, or cytotoxic chemotherapy to pursue the end point of tumor disappearance is perhaps an easy way out. Different end points, however, have to be sought to legitimate differentiation therapy. End point of the disappearance of circulating cancer stem cells, or restoration of plasma/urine peptide ratios to those of healthy people are valid, but need careful studies before being accepted as valid end points.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 60 pp. Englisch.…